Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Beth Stevens
Boston Children's Hospital, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Annexon Biosciences
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Stevens serves on the Scientific Advisory Board of Annexon, a company that is developing novel therapeutics for neurodegenerative and autoimmune disorders, with a focus on the classical complement cascade. Because of her expertise in the area, Dr. Stevens provides advice and guidance to the company regarding complement cascade function at synapses in animal models. The purpose of the subject research is to test whether blocking C1q and the classical compement cascade can reduce synaptic and circuit level phenotypes in mouse models and Annexon’s role in the research is provide my lab and collaborators with a research tool, a C1q blocking antibody to provide a mouse C1q blocking antibody As such, the outcome of the research has the potential to indirectly affect the Company.
Neural-immune mechanisms and synaptic connectivity in psychiatric illness
Project Narrative Our Center will work to reveal how genes and genetic variants, particularly in immune molecules, shape aspects of brain development that may go awry in neuropsychiatric illness. We will do this by deploying scientific approaches from neuroscience, immunology, and genomics.
Filed on October 03, 2017.
Tell us what you know about Beth Stevens's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Beth Stevens filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Beth Stevens | Boston Children's Hospital | Conflict of Interest | Annexon Biosciences | $0 - $4,999 |
| Beth Stevens | University of California Los Angeles | Conflict of Interest | Annexon Biosciences | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.